New therapies in endocrinology and diabetes
Wednesday 21 April 2010
Venue: The Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE
Registration Details:
RSM Fellow: £65
Associate: £45
Student Members: £30
Consultant/GP: £140
Trainee: £65
Allied Health Professional: £50
Student: £40
Meeting ref: EDA04
CPD (Applied for): 4 credits
9.30 am |
Registration, tea and coffee |
| Chair: Dr Arla Ogilvie, Watford General Hospital, London | |
10.00 am |
Introduction and welcome |
| Dr James Ahlquist, President of Endocrinology & Diabetes Section 2009-2010 | |
10.10 am |
Novel treatments and radionucleide therapy for neuroendocrine tumours |
| Professor Ashley Grossman, St Bartholomew's Hospital, London | |
10.45 am |
Optimising current glucocorticoid replacement and novel controlled-release therapy |
| Dr John Newell-Price, Sheffield University | |
11.20 am |
Tea and coffee break |
11.50 am |
DPP-IV inhibitors in type 2 diabetes-what have they added? |
| Professor David Leslie, St Bartholomew's Hospital, London | |
12.25 pm |
GPR119 agonists as potential new oral agents for type 2 diabetes and obesity |
| Dr Bernard Khoo, University College London | |
12.55 pm |
Lunch |
| Chair: Dr Michael Clements, Treasurer of Endocrinology & Diabetes Section 2009-2010 | |
2.00 pm |
Calcimimetics |
| Professor David Hosking, Nottingham University | |
2.35 pm |
Parathyroid hormone peptides, denosumab and emerging therapies for osteoporosis |
| Professor Juliet Compston, Cambridge University | |
3.10 pm |
Tea and coffee break |
3.30 pm |
Vaptans- role of vasopressin receptor antagonists in the management of hyponatraemia |
| Professor Christopher Thompson, Beaumont Hospital, Dublin | |
4.05 pm |
Completion of evaluation forms |
4.10 pm |
Treatment of acromegaly-roles for GH receptor antagonism and stereotactic radiosurgery |
| Professor Richard Clayton, University Hospital of North Staffordshire | |
4.45 pm |
Close of meeting |